Innovations in CNS drug discovery: differentiating strategies to treat depression.

Abstract

Over the past two decades, the clinical management of depression has been revolutionized by the introduction of selective serotonin re-uptake inhibitors and serotonin/noradrenaline re-uptake inhibitors. However, despite this progress, several unmet medical needs remain. These challenges, which collectively represent the next frontier for antidepressant drug… (More)
DOI: 10.1517/17460441.2.10.1369

Topics

Cite this paper

@article{Beyer2007InnovationsIC, title={Innovations in CNS drug discovery: differentiating strategies to treat depression.}, author={Chad E. Beyer and Zo{\"{e} A. Hughes}, journal={Expert opinion on drug discovery}, year={2007}, volume={2 10}, pages={1369-77} }